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Abstract 
Unnatural causes of death due to traffic accidents (TA) and suicide attempts (SA) constitute a 
major burden on global health, which remained stable in the last decade despite widespread efforts 
of prevention. Recently, latent infection with Toxoplasma gondii (T.gondii) has been suggested to be 
a biological risk factor for both TA and SA. Therefore, a systematic search concerning the relationship 
of T.gondii infection with TA and/or SA according to PRISMA guidelines in Medline, Pudmed and 
PsycInfo, was conducted collecting papers up to 11 February 2019 (PROSPERO #CRD42018090206). 
The random effect model was applied and sensitivity analyses were subsequently performed. Lastly, 
the population attributable fraction (PAF) was calculated. We found a significant association for 
antibodies against T.gondii with TA (OR=1.69; %95 CI: 1.20 – 2.38, p=0.003) and SA (OR=1.39; %95 CI: 
1.10-1.76, p=0,006). Indication of publication bias was found for TA, but statistical adjustment for this 
bias did not change the OR. Heterogeneity between studies on SA was partly explained by type of 
control population used (ORhealthy controls=1.9, p<0.001 versus ORpsychiatric controls=1.06, p=0.87) and 
whether subjects with schizophrenia only were analysed (ORschizophrenia=0.87, p=0.62 versus 
ORvarious=1.8, p<0.001). The association was significantly stronger with higher antibody titers in TA 
and in studies that did not focus on schizophrenia subjects concerning SA. PAF of a T.gondii infection 
was 17% for TA and 10% for SA. This indicates that preventing latent T.gondii infection may play a 
role in the prevention of traffic accidents or suicide attempts, although uncertainty remains whether 
this infection is truly causally related. 
 
Introduction 
 
Unnatural causes of death due to traffic accidents (TA) or suicide attempt (SA) constitute a 
major burden on global health. According to the World Health Organisation (WHO) about 1.4 million 
people die each year as a result of road injuries, rendering it among the ten leading causes of death 
globally for years(Naghavi et al., 2017). Between 20 and 50 million more people suffer from non-fatal 
road accidents, with many incurring a disability as a result of their injury. According to the WHO, TA 
are among the most important problems with regard to social, economic and human health 
issues(Naghavi et al., 2017). Likewise, suicide also has a huge impact on society, with 0.8 million 
people dying annually due to self-harm(Naghavi et al., 2017). For every fatal SA, 10 to 20 persons are 
estimated to attempt suicide, with approximately 10 million people attempting suicide worldwide 
annually(Turecki and Brent, 2016). 
 
Both these causes of unnatural death are considered to be multifactorial, with psychological, 
social and biological factors involved(Lutz et al., 2017, Turecki and Brent, 2016). Resources are 
directed at addressing modifiable factors in policymaking(Goniewicz et al., 2016, Herbert et al., 2017, 
Perron et al., 2013) (i.e. making more difficult to jump of bridges, increasing road safety, preventing 
drug abuse) and healthcare(Gilissen et al., 2017, Goniewicz et al., 2016, Turecki and Brent, 2016) 
(improved immediate care for people involved in a car crash, lowering barriers for people with 
suicidal ideation to receive help) in order to diminish health burden. These interventions showed 
regional successes although without affecting global mortality rates in the last decade(Naghavi et al., 
2017). Recently, a hitherto unsuspected, but potentially modifiable biological factor has received 
increasing attention with its association to both SA and TA: the latent infection with Toxoplasma 
gondii (T.gondii) (Flegr et al., 2009, Pedersen et al., 2012).  
 
T.gondii is an intracellular and neurotropic parasite affecting most of warm-blooded animals 
including humans. In humans, infection is acquired by ingestion of contaminated water or food that 
contains tissue cysts. It is estimated that approximately 30% of the global population is infected with 
the parasite, with large regional variances(Montoya and Liesenfeld, 2004). The parasite has a 
complex life cycle, whereby it needs to end up in the intestine of felines (cats) in order to complete 
its lifecycle(Montoya and Liesenfeld, 2004). Interestingly, non-feline mammals show cognitive and 
behavioural changes that increase their risk of being caught by felines(Berdoy et al., 2000, Webster, 
2007b), which are considered evolutionary adaptations of the parasite facilitating its survival. There 
is evidence that the parasite accomplishes this behavioural change by influencing neurotransmitters 
in the brain(Flegr, 2013, Parlog et al., 2015). Studies have shown that the parasite is able to increase 
dopamine release in infected neurons(Prandovszky et al., 2011) and potentially influences the 
kynurenine pathway, which could influence glutamate signalling(Notarangelo et al., 2014). 
Since these findings emerged, research focussed increasingly on possible cognitive and 
behavioural changes by a latent T.gondii infection in humans. Indeed, neurocognitive changes have 
been reported in people with a latent T.gondii infection, whereby increased impulsiveness has been 
reported in people with T.gondii infection, although results so far are heterogeneous(Dickerson et 
al., 2014, Gale et al., 2015, Peng et al., 2018, Sugden et al., 2016b). Nonetheless, meta-analyses did 
show overall a significant association of exposure to T.gondii with several psychiatric disorders, 
especially schizophrenia, suggesting that the infection could impact human behaviour as 
well(Sutterland et al., 2015). 
The objective of the study was to determine if T.gondii infection is indeed associated with SA 
and/or TA by conducting a systematic review and meta-analysis.  
 
Methods 
We followed the systematic review guidelines provided by the PRISMA statement(Moher et 
al., 2009). We conducted a systematic search (see Appendix 1) throughout Medline, PsychInfo and 
EMBASE until 11th February 2019 (Prospero #CRD42018090206).  
Inclusion criteria were: (i) original research papers with comparable quantitative data; (ii) any 
language; (iii) analysis of latent T.gondii infection by measuring IgG antibodies using one of the 
following diagnostic assays: Sabin-Feldman dye test, complement fixation, immune 
hemagglutination, immune fluorescence or enzyme-linked immunosorbent assay (ELISA); (iv) case-
control or cohort studies with human subjects; (v) data on SA and/or TA. Exclusion criteria were: (i) 
studies without a control group, (ii) case reports or case series and (iii) studies with 
immunocompromised patients. Additional studies were sought in references of all reviews on this 
topic. Screening of search results by manuscript titles and abstracts, were performed by three 
researchers (AS, BK, AK). Final screening by reading the whole manuscript was performed to validate 
inclusion (AS, AK). The corresponding authors were asked to provide additional data if not included in 
the original publications and for unpublished results.  
All selected articles were screened on study quality independently by two researchers (AS, 
GF) following Cochrane criteria of quality on case-control or cohort studies(Higgins et al., 2011). If 
there was a difference in quality score, the difference was discussed. If consensus could not be 
reached, a third opinion was asked (LdH) for a final decision.  
 Some studies included only subjects that had committed suicide attempts as cases (for 
example cases presented at the emergency department due to a suicide attempt) and collected 
healthy controls as a control population in order to compare antibody levels against T.gondii. In 
contrast, other studies looked at subjects with certain psychiatric disorder(s) cross-sectionally and 
defined caseness as having a history of suicide attempt(s) and control population as subjects not 
having this history. In order to study whether this difference in sampling method mattered, we 
stratified these studies based on the type of control population used.” 
 
Meta-analysis of eligible studies 
For all studies an Odds Ratio (OR) was calculated. ORs adjusted for confounders were used if 
available. The random effects model was applied for all analyses. Heterogeneity was assessed by eye-
balling and calculating I-squared (I2). Meta-analytical calculations were carried out with 
Comprehensive Meta-analysis Software 3.0(Borenstein et al., 2013). 
Effect of potential moderators on heterogeneity was assessed if possible (study quality, mean 
age, sex, seroprevalence of the control population, fatality, type of control population, diagnosis of 
cases and timing of outcome measurement: prospective or retrospective). Whether studies had a 
prospective design was determined based on fulfilment of one of the following two criteria: a. The 
study was designed as a longitudinal cohort study whereby the seropositivity to T.gondii preceded 
the outcome (TA or SA) or b. In a cross-sectional study the outcome (TA or SA) had occurred at or 
shortly before measurement of IgG antibodies against T.gondii (since these antibodies are indicative 
of a latent infection and emerge months after primary infection).  
Considering diagnosis of cases, specifically for SA, studies were grouped in studies that had 
included only cases with schizophrenia (schizophrenia only) compared to studies that had included 
other or any psychiatric disorder (various psychiatric disorders).  
Where applicable meta-regression analysis (for continuous data) or subgroup analysis (for 
categorical data) were performed with the methods of moments and the mixed effects model 
respectively(Borenstein et al., 2009).  
To assess by which proportion moderators influenced variance of the true effect, regression 
analyses were performed investigating the moderator as covariate. The amount of variance was 
expressed by R-squared. Due to the number of included studies, moderator effects were analyzed 
individually(Borenstein et al., 2009). 
For seropositivity definition, cut-off scores used for the assays in the respective studies were 
followed. If multiple assays were used in a study, we utilized the results of the assay that showed the 
smallest difference.  
Higher average antibody titers (compared to controls) has been called serointensity, whereby 
preferably numbers on high versus low, but still positive, antibody titers were used to see if this 
influenced magnitude of the OR. If these were not available, average titers in groups were used and 
converted into an OR.  
The potential for publication bias was assessed by examination of funnel plots and by the 
Egger’s test (which was considered significant if the one-sided p value was <0.10). If applicable, Duval 
and Tweedie’s trim and fill method was used for a better estimation of the true OR. 
Since the global incidence of traffic accidents and suicide attempts are both low (0,3 - 0,7% 
per year and 0.14% per year respectively), OR becomes identical to the risk ratio (RR)(Zhang and Yu, 
1998). As the current meta-analysis provides an estimation of ORs and the global prevalence (Pglob) 
of a latent T.gondii is estimated to be 30%(Montoya and Liesenfeld, 2004), the population 
attributable fraction (PAF) can be calculated. The formula PAF = (Pglob* (RR-1))/(Pglob *(RR-1)+1) 
was applied(Levin, 1953). 
 
Results  
The systematic search rendered in total 715 studies. After duplicate removal 636 studies 
remained. After title and abstract screening for inclusion criteria 51 studies were selected for full-text 
screening. Ten studies were added after reference screening of reviews. After full-text screening, 24 
studies were finally selected for quantitative synthesis, with a total of 4229 cases and 12234 controls 
in TA and 2259 cases and 9400 controls in SA (see Figure 1 for flowchart and Table 1 for study 
characteristics).   
 Traffic Accidents: 
In total eleven studies comparing seropositivity to T.gondii with the risk of being involved in a 
traffic accident were identified (Alvarado-Esquivel et al., 2015, Burgdorf et al., 2019, Flegr et al., 
2002b, Flegr et al., 2009, Galvan-Ramirez Mde et al., 2013, Kocazeybek et al., 2009b, Samojlowicz et 
al., 2013, Shotar et al., 2016, Stepanova et al., 2017, Sugden et al., 2016a, Yereli et al., 2006), 
showing an overall OR of 1.69 (%95 CI: 1.20 – 2.38, P = 0.003), see Figure 2. The Egger’s test did 
indicate presence of publication bias (p=0.06), however the Duval and Tweedie’s trim and fill 
rendered the same OR using the random effects model if missing studies were searched left from the 
mean. Also, the funnel plot using the random effects model did not indicate publication bias 
(Appendix 2). Heterogeneity was considerable and significant (I2= 86%, p<0.0001, Tau2=0,247). 
To explore heterogeneity, moderators were assessed for their impact on the between study 
variance. No effect of overall study quality on OR was found. Noteworthy, when quality of the 
definition of cases in TA was considered separately, the OR was significant in studies using a more 
concise description of traffic accidents (excluding alcohol use, making sure the driver was responsible 
for the accident), as opposed to those with broader inclusion criteria. Importantly, studies selectively 
assessing fatal TA as well as studies measuring antibodies against T.gondii occurring directly after or 
before the occurrence of TA (representing prospective study designs, as IgG antibodies against 
T.gondii represents a latent infection) both showed significant associations (Table 2a). 
None of the moderators had significant impact on the variance of the overall effect. 
 
Serointensity and TA 
In total five studies reported serointensity(Flegr et al., 2002a, Flegr et al., 2009, Galvan-
Ramirez et al., 2013, Kocazeybek et al., 2009a, Shotar et al., 2016). Overall, the odds for TA were 
increased in cases with high titers compared to low titers; OR 1.75 (95% CI 1.28 – 2.38; p<0.001). 
Significant heterogeneity was present (I2=65%, Tau 0.299), for which no explanation was found with 
available moderators (seroprevalence, age, quality, study design).  
 
Suicide Attempts or Suicide 
Thirteen studies studying the association between SA and latent T.gondii infection and one 
unpublished study were identified(Alvarado-Esquivel et al., 2013, Ansari-Lari et al., 2017, Arling et al., 
2009, Bak et al., 2018, Burgdorf et al., 2019, Coryell et al., 2016, Fond et al., 2015, Kuiper et al., 
Okusaga et al., 2011, Pedersen et al., 2012, Samojlowicz et al., 2013, Sugden et al., 2016b, Yagmur et 
al., 2010, Zhang et al., 2012), with an overall OR of 1.39 (%95 CI: 1.10-1.76, p=0,006), see Figure 3. 
One of the studies provided data on suicide deaths, violent SA as well as self-directed 
violence(Pedersen et al., 2012). Subjects with self-directed violence were excluded from the analysis. 
The Egger’s test did not indicate presence of publication bias (p=0.15) and Duval and Tweedie’s trim 
and fill analysis using the random effects model rendered a similar and significant OR. There was 
evidence of heterogeneity (I2=55%, p=0.003, Tau2=0.103). 
To explore heterogeneity, moderators were assessed for their impact on the between study 
variance. Two moderators had significant impact on the between study variance: the proportion of 
patients with schizophrenia (schizophrenia only versus various psychiatric disorders) 
(ORschizophrenia=0.87 (95%CI: 0.51 – 1.49), p= 0.62 versus ORvarious=1.8 (95%CI: 1.44 – 2.24), p < 0.001) 
and whether the control population consisted of healthy controls or patients with psychiatric 
disorders (ORhealthy controls=1.9 (95%CI: 1.48 – 2.44), p<0.001 versus ORpsychiatric controls=1.06 (95%CI: 0.70 – 1.61), 
p=0.78) (Table 2b). In order to determine whether the effect of one moderator could drive the other, 
the effect of diagnosis within studies that used controls with psychiatric disorders was assessed post-
hoc in studies with various psychiatric disorders as control subjects (n=4) compared with only 
schizophrenia as control subjects (n=5). A non-significant larger association was found (ORvarious= 1.49 
(95%CI: 0.71 – 3.15), p=0.29 versus ORschizophrenia=0.87 (95%CI: 0.51 – 1.49), p=0.62; Q-between 1.32, 
p=0.25, R2=0%). It was not possible to investigate the reverse, since all studies investigating SA in 
subjects with schizophrenia did not use healthy controls as comparison. 
Importantly, studies that selectively assessed SA within a prospective design as well as fatal 
SA showed significant associations with T.gondii infection (Table 2b). 
Even though type of diagnosis of case population or type of control population explained a 
(trend-)significant amount of between study variance, the estimated proportion of between-study 
variance was 0% for both moderators as expressed by R2. 
 
Serointensity and SA 
Eight studies reported serointensity(Alvarado-Esquivel et al., 2013, Ansari-Lari et al., 2017, 
Arling et al., 2009, Bak et al., 2018, Fond et al., 2015, Okusaga et al., 2011, Pedersen et al., 2012, 
Zhang et al., 2012), rendering an overall OR of 1.22 (%95 CI: 0.96 – 1.55, p=0,11). There was no 
indication of publication bias (Egger’s test p=0.17). The heterogeneity of the observed effects 
between studies was high (I2=62%, p=0.004, Tau=0.252). When exploring possible reasons for the 
heterogeneity, there was a significant effect of studies focussing on subjects with schizophrenia (n=5) 
versus various other psychiatric disorders (n=5): OR 0.99 (95%CI: 0.77 – 1.29) versus OR 1.66 (95%CI: 
1.29 – 2.12, p<0.001), R2=61%, p=0.004. 
 
PAF 
Assuming an average infection rate of T.gondii of 30% in humans globally the calculated PAF, 
(0.3*(OR-1))/(0.3*(OR-1)+1), showed that if T.gondii infection would theoretically be completely 
prevented the casualties due to TA would decrease with approximately 17% (95%CI: 6 - 29%) and due 
to suicide attempts with 10% (95%CI: 3 – 19%). 
 
Discussion 
Overall we found significant associations between a T.gondii infection and both SA and TA. 
Importantly, the associations did not seem to be influenced by publication bias. If the associations 
would be explained by the causal hypothesis, i.e. that the T.gondii infection influences the risk of 
commiting a SA or suffering a TA, this would imply that a latent T.gondii infection would lead to much 
more morbidity and mortality than hitherto assumed. Taking into account the calculated PAFs,  
T.gondii infection would emerge as a major public health concern, comparable with global meningitis 
mortality, with an estimated 318 thousand annual deaths potentially due to the behavioural effects 
of this infection(Naghavi et al., 2017). Therefore, it is paramount to evaluate whether the results of 
current meta-analysis and the available literature to date indeed provide enough support for the 
plausibility of a causal relationship and whether alternative explanations for these associations could 
be given. 
When assessing whether a factor (here a T.gondii infection) could be causal to a certain 
condition, Koch’s postulates of causality can be used as a theoretical framework(Antonelli and Cutler, 
2016). The postulates that need to be addressed in order for a factor to be considered causal to a 
certain condition are: consistency of the relationship, a temporal relationship (the factor preceding 
the emergence of the condition), a gradient in the relationship (more exposure to the factor leads to 
a higher risk of getting the condition), experimental proof of the relationship and a plausible 
biological mechanism.  
The consistency of the relationship is addressed with the current meta-analysis. Overall the 
associations were significant, although the amount of studies was modest and heterogeneity high. In 
TA the Egger’s test indicated presence of publication bias. Nevertheless, statistical adjustment for 
possible bias by the Duval and Tweedie’s trim and fill analysis did not change the overall finding. This 
is probably due to the different underlying mathematical method these tests use. The Egger’s test 
relies on the fixed effects model to see whether the sample size influences overall effect, whereas 
the Duval and Tweedie’s trim and fill analysis can be applied to both the fixed and random effects 
model(Borenstein et al., 2009). This implies that the Egger’s test relies more heavily on sample size, 
whereby the large Danish cohort study that found a small but significant association of T.gondii with 
TA, has a very large weight (>70%) relative to the other studies (all 5% or less)(Burgdorf et al., 2019). 
When funnel plots were examined using both the fixed and random effects model, it became clear 
that with the random effects model (which gives relatively less weight to large studies than the fixed 
effects model) there does not seem to be publication bias (see Appendix 2). Additionally, even when 
the fixed effects model was used for statistical correction, the OR remained significantly increased 
albeit smaller (data available upon request). In our view, despite the significant Egger’s test, the data 
still indicate a relationship between T.gondii and TA, although the magnitude is less certain.  When 
exploring heterogeneity in TA, assessable moderators explained a negligible and non-significant 
amount of the observed variance. In favour of the consistency of the relationship with TA was that 
the OR seemed to be stronger when studies were grouped which had carefully selected subjects with 
a higher chance to have influenced their own risk of becoming involved in TA (not intoxicated, having 
caused the accident as a driver).  
In SA there was no indication of publication bias, but (trend-)significant effects on 
heterogeneity were found among studies that included subjects with schizophrenia only and those 
that used healthy subjects as control population. A secondary analysis seemed to indicate that 
selection of schizophrenia cases is particularly important, whereby the association of T.gondii 
infection with SA was absent in cases with schizophrenia. This might be due to the fact that T.gondii 
infection is a risk factor for schizophrenia in itself(Sutterland et al., 2015) or that the infection has 
little effect on suicidality in schizophrenia specifically, where other factors may overshadow such a 
relationship. For example, Toxoplasma infection has been associated with dopamine modulation in 
brain neurons(Prandovszky et al., 2011), while dopamine disturbances are generally recognized 
abnormalities described in the brain of most subjects with schizophrenia whether or not they are 
infected with T.gondii(Howes et al., 2017). Nonetheless, the association of T.gondii infection with SA 
being partly explained by using healthy subjects as controls remains a concern, suggesting the higher 
prevalence of antibodies against T.gondii in several psychiatric disorders might drive the association. 
On one hand this possible confouding seems less likely as the large cohort study of Pedersen and 
colleagues was able to control for psychiatric disorders in the population and still showed a 
significant association between T.gondii infection and suicidal behaviour(Pedersen et al., 2012), but 
on the other hand the study of Burgdorf and colleagues found a small but non-significant effect, 
whereby they used a different method to control for psychiatric disorders in the population(Burgdorf 
et al., 2019). Future studies should keep trying to disentangle these confounding factors and assess 
other potential factors influencing heterogeneity. One of those candidates is Rhesus factor positivity, 
which has been suggested as relevant(Flegr et al., 2009, Flegr et al., 2013). For example, cognitive 
dysfunction was only found in subjects with a latent T.gondii infection which were Rhesus negative. 
Why the Rhesus factor could protect humans against deletorial effects of T.gondii is unclear. Another 
candidate to explore is the strain hypothesis, whereby strains of T.gondii differ in virulence and 
possibly in ability to influence human behaviour(Xiao et al., 2009). This strain hypothesis was first 
explored by a study of Xiao et al., whereby the association of T.gondii infection with affective 
psychosis was only found in a subgroup who were infected with strain type I and not with type II or 
other types (Xiao et al., 2009). Since then, one study has found a similar effect with strain type I in 
humans(Groer et al., 2011). 
 The postulate of a temporal relationship seemed plausible as studies with a prospective 
design rendered similar findings indicating the infection preceded the outcome. Additionally, the 
serointensity analyses showed that significant increases in the ORs were found with higher antibody 
titres for TA and for SA, the latter within studies that did not include schizophrenia cases only. This 
could imply that the severity of the infection plays a role, indicating a gradient in the relationship. 
Nevertheless, it is much less clear if Toxoplasma prevalence influences numbers of SA and TA. One 
study has suggested that a relationship between national T.gondii prevalence and suicide incidence 
in European countries exists(Lester, 2010). On the other side, suicide numbers have varied 
considerably the last decades, while it has been suggested that T.gondii prevalence steadily 
decreased in the same time period(Dyvesether et al., 2018, Gargate et al., 2016, Huikari et al., 2019, 
Jones et al., 2014). This last fact could be explained by other factors that have a bigger impact on 
suicide numbers than Toxoplasmosis (which has an estimated PAF of 10%), such as the 
unemployment rates(Huikari et al., 2019). Concerning TA, no study to date has examined if regional 
T.gondii prevalence is related to TA numbers. 
The experimental proof for a relationship is challenging with the studied outcomes. Animal 
models have been examined, which could be applicable for these outcomes. Several behavioural 
changes after infection with T.gondii in mice and rats have been documented, including increased 
reaction time, slower neural processing speed, decreased attention span and increased risk taking 
behaviour(Daniels et al., 2015, Tan et al., 2015, Webster, 2007a). These factors can increase the risk 
of both TA and SA. However, the methodology underlying these findings have been 
questioned(Worth et al., 2014). Human studies have indicated cognitive abnormalities concurring 
with T.gondii infection, increasing the risk of suffering from TA(Guenter et al., 2012, Pearce et al., 
2013, Pearce et al., 2014). However, these findings were not always replicated(Gale et al., 2015, 
Sugden et al., 2016b).  
Finally, a plausible biological mechanism should be available to explain how a latent T.gondii 
infection could lead to an increased risk of causing TA and SA. Several biological mechanisms have 
been postulated. First of all, as tryptophan is essential for T.gondii replication, increased tryptophan 
breakdown by activating the kynurenine pathway is a major line of defence for the host against 
T.gondii infection, leading to increased kynurenine (KYN) and quinolinic acid (QUIN) levels(Miller et 
al., 2009). Increased KYN as well as QUIN levels, including in CSF and post-mortem, have been 
associated with suicidal behaviour(Erhardt et al., 2013, Steiner et al., 2012, Sublette et al., 2011). 
Okusaga and colleagues found that the risk of SA was increased in cases with both seropositivity to 
T.gondii and high KYN levels(Okusaga et al., 2016). QUIN is a N-methyl-D-aspartate (NMDA) receptor 
agonist and considered to be neurotoxic, whereby recent evidence indicates that ketamine, a NMDA 
receptor antagonist can acutely reduce suicidality(DiazGranados et al., 2010). Secondly, it has been 
demonstrated that a T.gondii infection can increase dopamine levels both in vitro and in 
mice(Prandovszky et al., 2011, Skallova et al., 2006). The genome of T.gondii is able to express the 
enzyme tyrosine hydroxylase in infected cells, which is the rate-limiting enzyme in dopamine 
synthesis(Prandovszky et al., 2011). Hyperdopaminergic states, together with NMDA agonism can 
lead to increased arousal, neurotoxicity and impulsivity(Barake et al., 2014).  
Although the suggested biological mechanisms may be plausible, studies confirming the role 
of one of these mechanisms in humans are challenging and remain scarce(Okusaga et al., 2016).   
 
 Alternative explanations for an association between T.gondii infection and both SA and TA 
should be explored as well. As it is known that felines are the definite host of the parasite, 
households with cats are more prone to get infected by T.gondii. While we are unaware of studies 
showing that families who prefer cats as pets are also more prone to psychiatric illness, SA or TA, this 
reverse causality cannot be ruled out. Conversely, evidence that households with cats have an 
increased risk of developing schizophrenia has been published(Torrey et al., 2015), although these 
findings have been challenged and are to date still unclear(Solmi et al., 2017).  
When elaborating further on factors that could give rise to a so called spurious association 
(i.e. toxoplasmosis and TA or SA are not directly related to each other but both rise or fall due to 
another factor), it should be noted that households with low incomes are known to be at a higher 
risk of being involved in a TA or committing a SA(Ghaffar et al., 2004, Hawton and van Heeringen, 
2009, Qin et al., 2003). There is indication that this could also be applicable to the risk of contracting 
a latent T.gondii infection(Mareze et al., 2019). Studies included in our meta-analysis did not adjust 
for socio-economic status, which would be important to examine in future studies.  
 Furthermore, it is possible that the biological susceptibility of humans to contract a latent 
T.gondii infection, for example through differences in the immune defence system or reactivity of the 
kynurenine pathway, also influences the risk of TA and SA. In SA, many studies have shown changes 
in cytokine profiles in cases compared to controls(Gananca et al., 2016), but in TA this has not been 
examined as far as we are aware. More studies with a prospective design looking into biological 
susceptibility are needed to shed further light on this matter. 
 
Strengths and limitations 
 One of the strengths of the meta-analysis is the extensive sensitivity analysis addressing 
heterogeneity, after retrieval of additional data from several authors. This showed variation in the 
association of SA with T.gondii infection, due to several factors, which can guide the field in further 
research into this topic. It was also able to demonstrate that the severity of T.gondii infection further 
increased the association with SA and TA and that the infection precedes these adverse outcomes. 
One of the limitations however, is that the amount of studies were still relatively modest, leaving 
some uncertainty about the robustness of the finding and limiting options for sensitivity analyses 
with multiple moderators at once. Another limitation was that it was not possible to use individual 
patient data. 
 
Conclusion  
Overall, the findings of this meta-analysis in conjunction with the available literature provides 
substantial evidence that a latent T.gondii infection may play an important role in the risk of TA and 
SA. Nevertheless, the additional impact that toxoplasmosis potentially has on health (besides the 
well-known consequences in immunocompromised patients and de novo infection during 
pregnancies and the possible mental health consequences(Montoya and Liesenfeld, 2004)), validates 
the question what the gain could be for devoting more public health resources into this issue. 
Further research concerning prevention of primary infections on a larger scale should be considered. 
It is presumed that transmission occurs most often through ingestion of intact oocysts containing the 
parasite, which can be contracted by eating raw or undercooked meat, changing cat litter, by not 
washing hands after gardening, eating unwashed vegetables or fruit or by drinking contaminated 
water(Montoya and Liesenfeld, 2004). It would be good to increase the knowledge about the most 
common route of transmission in humans and try to prevent this. Alternatively, resources could be 
directed into developing a vaccine for humans or cats. Secondly, little is known how to diminish or 
prevent deleterious consequences by an acquired latent infection. Targeting specific high-risk 
populations, such as traffic offenders or people who have committed a SA could be an option to 
investigate these questions. Finally, possible candidates that could be responsible for the 
heterogeneous findings (rhesus factor positivity, differences in strain virulence, type of case and 
control population) should be explored further. 
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